C-reactive protein and nitric oxide level in patients with white coat hypertension

References

• Karter Y, Curgunlu A, Altınişik S, Ertürk N, Vehid S, Mihmanli I, . Target organ damage and changes in arterial compliance in white coat hypertension. Is white coat innocent? Blood Press. 2003;12:307–313.
   PubMed Web of Science ®Google Scholar
• Polonia JJ, Gama GM, Silvia A, Amaral C, Martins LR, Bertequini SE. Sequential follow-up clinic an ambulatory blood pressure evaluation in a low risk population of white-coat hypertensive patients and in normotensives. Blood Pressure Monitoring. 2005;10:57–64.
   Google Scholar
• Marchi-Alves LM, Carnio EC. Is there any correlation between insulin resistance and nitrate plasma concentration in white coat hypertensive patients? Cardiol Res Pract. 2009;2009:376735.
   PubMedGoogle Scholar
• Pierdomenico SD, Bucci A, Costantini F, Lapenna D, Cuccurullo F, Mezzetti A. Twenty-four-hour autonomic nervous function is sustained and ‘white coat’ hypertension. Am Heart J. 2000;140:672–677.
   PubMed Web of Science ®Google Scholar
• Bian K, Doursout MF, Murad F. Vascular system: Role of nitric oxide in cardiovascular diseases. J Clin Hypertens. 2008;10:304–310.
   Google Scholar
• Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991; 43:109–142.
   PubMed Web of Science ®Google Scholar
• Node K, Kitakaze M, Yoshikawa H, Kosaka H, Hori M. Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension. Hypertension. 1997;30: 405–408.
   Google Scholar
• Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet. 1997;349:837–842.
   PubMed Web of Science ®Google Scholar
• Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in in the abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. Circulation. 1993;87:1468–1474.
   PubMed Web of Science ®Google Scholar
• Iiyama K, Nagano M, Yo Y, . Impaired endothelial function with essential hypertension assessed by ultrasonography. Am Heart J. 1996;132:779–782.
   PubMed Web of Science ®Google Scholar
• Joannides R, Haefeli WE, Linder L, . Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995;91: 1314–1319.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336: 973–979.
   PubMed Web of Science ®Google Scholar
• Koenig W, Sund M, Frohlich M, . C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Chort Study, 1984 to 1992. Circulation. 1999;99:237–242.
   PubMed Web of Science ®Google Scholar
• Tracy RP, Lemaitre RN, Psaty BM, . Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: Results from the Cardiovascular Health Study and Rural Health Promotion Project. Arterioscler Thromb Vasc Biol. 1997;17:1121–1127.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000; 342:836–843.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557–1565.
   PubMed Web of Science ®Google Scholar
• Ford ES, Giles WH. Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction: Findings from National Health and Nutrition Examination Survey III. J Clin Epidemiol. 2000; 53:95–102.
   PubMed Web of Science ®Google Scholar
• Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationship among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol. 2002;22:1668–1673.
   PubMed Web of Science ®Google Scholar
• Verma S, Wang CH, Li SH, . A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002;106:913–919.
   PubMed Web of Science ®Google Scholar
• Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation. 2002;106:1439–1441.
   PubMed Web of Science ®Google Scholar
• Verma S, Li SH, Badiwala MV, . Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation. 2002;105: 1890–1896.
   PubMed Web of Science ®Google Scholar
• Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor–1 expression and activity in human aortic endothelial cells: Implications for the metabolic syndrome and atherothrombosis. Circulation. 2003;107: 398–404.
   PubMed Web of Science ®Google Scholar
• Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem. 1990;36:1440–1443.
   PubMed Web of Science ®Google Scholar
• Moshage H, Kok B, Huizenga JR, Jansen PL. Nitrite and nitrate determinations in plasma: A critical evaluation. Clin Chem. 1995;41:892–896.
   PubMed Web of Science ®Google Scholar
• Pepys MB, Hirschfield GM. C-reactive protein: A critical update. J Clin Invest. 2003;111:1805–1812.
   PubMed Web of Science ®Google Scholar
• Liuzzo G, Biasucci LM, Gallimore JR, . The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 1994;331:417–424.
   PubMed Web of Science ®Google Scholar
• Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med. 1995;332:635–641.
   PubMed Web of Science ®Google Scholar
• Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet. 1997;349:462–466.
   PubMed Web of Science ®Google Scholar
• Danesh J, Wheeler JG, Hirschfield GM, . C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387–1397.
   PubMed Web of Science ®Google Scholar
• Verma S, Anderson TJ. The ten most commonly asked questions about endothelial function in cardiology. Cardiol Rev. 2001;9:250–252.
   Google Scholar
• Wang CH, Li SH, Weisel RD, . C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation. 2003;107:1783–1790.
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med. 1999;340:115–126.
   PubMed Web of Science ®Google Scholar
• Todd ME. Hypertensive structural changes in blood vessels: Do endothelial cells hold the key? Can J Physiol Pharmacol. 1992;70:536–551.
   Google Scholar
• Tracy RP, Lemaitre RN, Psaty BM, . Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol. 1997;17:1121–1127.
   PubMed Web of Science ®Google Scholar
• Glen SK, Elliott HL, Curzio JL, Lees KR, Reid JL. White-coat hypertension as a cause of cardiovascular dysfunction. Lancet. 1996;348:654–657.
   PubMed Web of Science ®Google Scholar
• Palatini P, Mormino P, Santonastaso M, . Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: Results from the HARVEST study. Hypertension. 1998;31:57–63.
   PubMed Web of Science ®Google Scholar
• Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: A 10-year follow-up study. Circulation. 1998;98:1892–1897.
   PubMed Web of Science ®Google Scholar
• Pierdomenico SD, Cipollone F, Lapenna D, Bucci A, Cuccurullo F, Mezzetti A. Endothelial function in sustained and white coat hypertension. Am J Hypertens. 2002;15:946–952
   PubMed Web of Science ®Google Scholar
• Conen D, Dieterle T, Utech K, Rimner M, Martina B. C-reactive protein and B-type natriuretic peptides in never-treated white coat hypertensives. Hypertens Res. 2006;29: 411–415.
   Google Scholar
• Schillaci G, Pirro M, Gemelli F, . Increased C-reactive protein concentrations in never-treated hypertension: The role of systolic and pulse pressures. J Hypertens. 2003;21: 1841–1846.
   PubMed Web of Science ®Google Scholar